On May 23, 2016 Varian Medical Systems (NYSE: VAR) reported that The University of Texas MD Anderson Cancer Center signed an agreement to acquire six TrueBeam linear accelerators (Press release, InfiMed, MAY 23, 2016, View Source [SID:1234512712]). Scheduled for delivery over the next 24 months, the six TrueBeam systems will be added to the 24 Varian linear accelerators already treating patients at the cancer center.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"We have been able to deliver critical cancer treatments to thousands of cancer patients as well as collaborate on strong translational research programs and clinical trial support through Varian’s technology," said Steve Hahn, chair, Division of Radiation Oncology at MD Anderson Cancer Center. "The additional TrueBeam systems will enable us to make advanced cancer care accessible to even more patients."

Varian’s TrueBeam system is an advanced medical linear accelerator capable of fast and precise image-guided radiotherapy and radiosurgery. The system is equipped with a high dose delivery rate that enables most treatments to be completed faster than was possible with earlier generations of radiotherapy technology. It incorporates numerous technical innovations that dynamically synchronize imaging, patient positioning, motion management, and dose delivery during a treatment procedure. TrueBeam has been designed to advance the treatment of lung, breast, intracranial, prostate, head and neck, and other types of cancer.

"Varian is proud of its years of working with MD Anderson," said Kolleen Kennedy, president of Varian’s Oncology Systems business. "We have worked together to improve the quality and effectiveness of cancer care for patients who come from all over the world for treatment. TrueBeam opens the door to some exciting cutting-edge treatment capabilities that will be made available to patients in coming years."

The order for the systems was booked in March during the second quarter of the company’s fiscal year 2016.